Stay updated on GVAX Pancreas Vaccine Combos With Nivolumab Clinical Trial
Sign up to get notified when there's something new on the GVAX Pancreas Vaccine Combos With Nivolumab Clinical Trial page.

Latest updates to the GVAX Pancreas Vaccine Combos With Nivolumab Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 is displayed, replacing the previous v3.4.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added. The previous government funding notice and the older revision notice (v3.4.1) were removed.SummaryDifference0.4%

- Check41 days agoChange DetectedSite-wide notices about government funding and operating status were added, and the site revision updated to v3.4.1; there are no changes to the study details or content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedThe page adds a glossary display option and a new 'Last Update Submitted that Met QC Criteria' field, removes the 'No FEAR Act Data' indicator, and updates the system revision from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now shows the revision tag 'Revision: v3.3.4', replacing 'v3.3.3'; this is a minor update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a dedicated Locations section listing study sites by state (California, Maryland, Oregon, Pennsylvania) and updated the page revision to v3.3.3, replacing the previous California Locations, Maryland Locations, Oregon Locations, and Pennsylvania Locations entries.SummaryDifference0.5%

Stay in the know with updates to GVAX Pancreas Vaccine Combos With Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GVAX Pancreas Vaccine Combos With Nivolumab Clinical Trial page.